远程皮肤科驱动的日光性角化病局部治疗:临床有效性与依从性的比较研究
前瞻性纵向对照研究纳入157例单一日光性角化病患者,面对面组75例、远程皮肤科组82例,均用5%咪喹莫特乳膏治疗。符合方案分析完全缓解率两组无显著差异(66.7% vs 65.6%,P>0.05),意向性分析完全缓解率面对面组64.0% vs 远程组51.2%(P=0.073);总体缓解率面对面组84.0% vs 远程组70.7%(P=0.036);治疗完成率面对面组90.7% vs 远程组72.0%(P=0.004)。作者认为远程皮肤科作为常规管理方法前需改善初级保健中心对患者的咨询。
要点
- 符合方案分析完全缓解率面对面组66.7% vs 远程组65.6%,无显著差异(P>0.05)。
- 意向性分析完全缓解率面对面组64.0% vs 远程组51.2%(P=0.073)。
- 总体缓解率面对面组84.0% vs 远程组70.7%(P=0.036),治疗完成率90.7% vs 72.0%(P=0.004)。
核心结论
- 远程皮肤科管理日光性角化病的完全缓解率在符合方案分析中与面对面诊疗无显著差异,但意向性分析中远程组完全缓解率数值较低(P=0.073)。
- 面对面诊疗在总体缓解率和治疗完成率上优于远程皮肤科。
- 作者认为在将远程皮肤科作为日光性角化病常规管理方法前,需要改善初级保健中心的患者咨询。
研究设计与样本
- 前瞻性纵向对照研究,纳入157例单一日光性角化病患者,面对面诊疗组75例,远程皮肤科组82例,均接受5%咪喹莫特乳膏治疗。
主要发现
- 符合方案分析完全缓解率:面对面组66.7% vs 远程组65.6%(P>0.05)。
- 意向性分析完全缓解率:面对面组64.0% vs 远程组51.2%(P=0.073)。
- 面部位置和局部不良反应是意向性分析中完全缓解的唯一解释因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Teledermatology (TD) provides efficient care for skin cancer patients. OBJECTIVE: To compare the clinical effectiveness of imiquimod 5% for the treatment of AK with in-person care and through TD. METHODS: Longitudinal prospective controlled study including patients with single AK diagnosed and treated at face-to-face visits (FTF group) or through teledermatology (TD group) with imiquimod 5% cream. The main outcome measures assessed were the complete and global response percentage (CR and GR) under per-protocol (PP) and intention-to-treat (ITT) analysis. RESULTS: A total of 157 patients were enrolled (FTF = 75, TD = 82). PP analysis showed CR in 66.7% of FTF patients and 65.6% in TD patients (P > 0.05). The ITT yielded CR in 64.0% and 51.2% in FTF visits and TD, respectively (P = 0.073). The analysis showed an advantage of FTF care against TD in achieving GR (84.0% vs. 70.7%; P = 0.036). Facial location and local adverse reactions were the only explanatory factors of complete response in the ITT approach. Treatment completion was found in 90.7% and 72.0% in the FTF and TD groups, respectively (P = 0.004). CONCLUSIONS: Improvements in patient counselling at the primary care centre are needed before the implementation of TD as a routine methodology for the management of AK.
引用
- Ferrándiz L, Morales-Conde M, Fernández-Orland A, et al. Teledermatology-driven topical therapy of actinic keratosis: a comparative study of clinical effectiveness and compliance. J Eur Acad Dermatol Venereol. 2018. PMID: 29797670. doi:10.1111/jdv.15085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。